99 related articles for article (PubMed ID: 6605372)
21. Effect of previous infection on antibody response of children to vaccination with capsular polysaccharide of Haemophilus influenzae Type b.
Norden CW; Michaels RH; Melish M
J Infect Dis; 1975 Jul; 132(1):69-74. PubMed ID: 1080178
[TBL] [Abstract][Full Text] [Related]
22. An enzyme-linked immunosorbent assay for quantitation of Haemophilus Influenzae type b polysaccharide-specific IgG1 and IgG2 in human and infant rhesus monkey sera.
Dolan KT; Staub JM; Schofield TL; Ahonkhai VI; Ellis RW; Vella PP
J Immunoassay; 1991; 12(4):543-64. PubMed ID: 1806588
[TBL] [Abstract][Full Text] [Related]
23. Relationship between naturally occurring human mucosal and serum antibody to the capsular polysaccharide of Haemophilus influenzae type b.
Pichichero ME; Insel RA
J Infect Dis; 1982 Aug; 146(2):243-8. PubMed ID: 6980956
[TBL] [Abstract][Full Text] [Related]
24. The biology of Haemophilus influenzae type b vaccination failure.
Holmes SJ; Granoff DM
J Infect Dis; 1992 Jun; 165 Suppl 1():S121-8. PubMed ID: 1588145
[TBL] [Abstract][Full Text] [Related]
25. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
Miller MA; Meschievitz CK; Ballanco GA; Daum RS
Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
[TBL] [Abstract][Full Text] [Related]
27. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
Schlesinger Y; Granoff DM
JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
[TBL] [Abstract][Full Text] [Related]
28. Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines.
Englund JA; Glezen WP; Turner C; Harvey J; Thompson C; Siber GR
J Infect Dis; 1995 Jan; 171(1):99-105. PubMed ID: 7798688
[TBL] [Abstract][Full Text] [Related]
29. Safety and immunogenicity of Haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age.
Lepow ML; Samuelson JS; Gordon LK
J Pediatr; 1985 Feb; 106(2):185-9. PubMed ID: 3871477
[TBL] [Abstract][Full Text] [Related]
30. The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK.
Hazlewood M; Nusrat R; Kumararatne DS; Goodall M; Raykundalia C; Wang DG; Joyce HJ; Milford-Ward A; Forte M; Pahor A
Clin Exp Immunol; 1993 Aug; 93(2):157-64. PubMed ID: 8348740
[TBL] [Abstract][Full Text] [Related]
31. Development of respiratory mucosal tolerance during Haemophilus influenzae type B infection in infancy.
Rosales SV; Lascolea LJ; Ogra PL
J Immunol; 1984 Mar; 132(3):1517-21. PubMed ID: 6607287
[TBL] [Abstract][Full Text] [Related]
32. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children.
Siber GR; Santosham M; Reid GR; Thompson C; Almeido-Hill J; Morell A; deLange G; Ketcham JK; Callahan EH
N Engl J Med; 1990 Nov; 323(20):1387-92. PubMed ID: 2233905
[TBL] [Abstract][Full Text] [Related]
33. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
[TBL] [Abstract][Full Text] [Related]
34. [Tolerance and immunogenicity of the capsular polyoside vaccine against Haemophilus influenzae type b. A study of 325 children 15 to 71 months of age].
Reinert P; Postel-Vinay A; Bessa E; Hessel L; Schulz D; Cadoz M
Ann Pediatr (Paris); 1989 Jan; 36(1):20-5. PubMed ID: 2784652
[TBL] [Abstract][Full Text] [Related]
35. Safety and immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine (PRP-D) in infants.
Lepow ML; Barkin RM; Berkowitz CD; Brunell PA; James D; Meier K; Ward J; Zahradnik JM; Samuelson J; McVerry PH
J Infect Dis; 1987 Oct; 156(4):591-6. PubMed ID: 3497990
[TBL] [Abstract][Full Text] [Related]
36. [Vaccination of splenectomized children. Antibody response to Haemophilus influenzae type b conjugate vaccine].
Kristensen K
Ugeskr Laeger; 1994 Jan; 156(2):191-3. PubMed ID: 8296410
[TBL] [Abstract][Full Text] [Related]
37. Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity.
Kurono Y; Yamamoto M; Fujihashi K; Kodama S; Suzuki M; Mogi G; McGhee JR; Kiyono H
J Infect Dis; 1999 Jul; 180(1):122-32. PubMed ID: 10353870
[TBL] [Abstract][Full Text] [Related]
38. An idiotypic marker associated with a germ-line encoded kappa light chain variable region that predominates the vaccine-induced human antibody response to the Haemophilus influenzae b polysaccharide.
Lucas AH; Langley RJ; Granoff DM; Nahm MH; Kitamura MY; Scott MG
J Clin Invest; 1991 Dec; 88(6):1811-8. PubMed ID: 1752943
[TBL] [Abstract][Full Text] [Related]
39. Siblings of patients with Haemophilus meningitis have impaired anticapsular antibody responses to Haemophilus vaccine.
Granoff DM; Squires JE; Munson RS; Suarez B
J Pediatr; 1983 Aug; 103(2):185-91. PubMed ID: 6603504
[TBL] [Abstract][Full Text] [Related]
40. Immunity to Haemophilus influenzae type b polysaccharide capsule after vaccination with the complete series of oligosaccharide CRM197 conjugate vaccine in infants with human immunodeficiency virus infection.
Peters VB; Sood SK
J Pediatr; 1996 Mar; 128(3):363-5. PubMed ID: 8774505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
